Philipp Wendel

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma

Tobias Bexte, Jamal Alzubi, Lisa Marie Reindl et al. · OncoImmunology · 2022 · 77 citations · Full text

Life Sciences, Immunology, Oncology +17

CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells

Tobias Bexte, Nawid Albinger, Ahmad Al Ajami et al. · Nature Communications · 2024 · 72 citations · Full text

Life Sciences, Immunology, Molecular Genetics +12

Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors

Tobias Bexte, Lacramioara Botezatu, Csaba Miskey et al. · Molecular Therapy · 2024 · 44 citations · Full text

Life Sciences, Biotechnology, Immunology +15

CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML

Nawid Albinger, Tobias Bexte, Leon Buchinger et al. · Blood · 2022 · 22 citations

Medicine, Molecular Genetics, Oncology +16

Measuring Leukocyte Adhesion to (Primary) Endothelial Cells after Photon and Charged Particle Exposure with a Dedicated Laminar Flow Chamber

N. Erbeldinger, Felicitas Rapp, Svetlana Ktitareva et al. · Frontiers in Immunology · 2017 · 14 citations · Full text

Medicine, Biomedical Engineering, Radiation Biophysics +16